EVUSHELD
EVUSHELD
Discontinued
DIN Number
02526271
Drug Class
Human
Market Date
Apr 19, 2022
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526271
AIG Number0263541001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
J06BD03 TIXAGEVIMAB AND CILGAVIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification8:18.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
CILGAVIMABActive
Strength: 150 MG / 1.5 ML
Monograph: CILGAVIMAB
TIXAGEVIMABActive
Strength: 150 MG / 1.5 ML
Monograph: TIXAGEVIMAB